These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 27447238)

  • 1. Highlight: proteolytic networks across cellular boundaries.
    Clements J
    Biol Chem; 2016 Sep; 397(9):803. PubMed ID: 27447238
    [No Abstract]   [Full Text] [Related]  

  • 2. Highlight: the universe of proteolytic networks and mechanisms.
    Salvesen GS; Bogyo M
    Biol Chem; 2012 Sep; 393(9):841. PubMed ID: 22944685
    [No Abstract]   [Full Text] [Related]  

  • 3. Meeting report: 7th Fabisch Symposium for Cancer Research and Molecular Cell Biology--regulated intramembrane proteolysis in cancer development and neurodegenerative diseases.
    Kaden D; Multhaup G
    Neurodegener Dis; 2013; 11(4):215-8. PubMed ID: 22948275
    [No Abstract]   [Full Text] [Related]  

  • 4. Inflammation, cellular and redox signalling mechanisms in cancer and degenerative diseases.
    Aruoma OI; Bahorun T; Clement Y; Mersch-Sundermann V
    Mutat Res; 2005 Nov; 579(1-2):1-5. PubMed ID: 16054173
    [No Abstract]   [Full Text] [Related]  

  • 5. Systems biology for complex diseases.
    Chen L; Wu J
    J Mol Cell Biol; 2012 Jun; 4(3):125-6. PubMed ID: 22652391
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of 4-hydroxynonenal-protein adducts in human diseases.
    Barrera G; Pizzimenti S; Ciamporcero ES; Daga M; Ullio C; Arcaro A; Cetrangolo GP; Ferretti C; Dianzani C; Lepore A; Gentile F
    Antioxid Redox Signal; 2015 Jun; 22(18):1681-702. PubMed ID: 25365742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein damage, repair and proteolysis.
    Chondrogianni N; Petropoulos I; Grimm S; Georgila K; Catalgol B; Friguet B; Grune T; Gonos ES
    Mol Aspects Med; 2014 Feb; 35():1-71. PubMed ID: 23107776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
    Ciechanover A; Kwon YT
    Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic atlas of chaperome deregulation topologies across the human cancer landscape.
    Hadizadeh Esfahani A; Sverchkova A; Saez-Rodriguez J; Schuppert AA; Brehme M
    PLoS Comput Biol; 2018 Jan; 14(1):e1005890. PubMed ID: 29293508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activating or Inhibiting Nrf2?
    Chu XY; Liu YM; Zhang HY
    Trends Pharmacol Sci; 2017 Nov; 38(11):953-955. PubMed ID: 28886953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytosolic protein quality control system--the role of molecular chaperones in the biology of neurodegenerative diseases].
    Guenther I; Kedzierska-Mieszkowska S
    Postepy Biochem; 2011; 57(3):274-82. PubMed ID: 22235653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PMAP: databases for analyzing proteolytic events and pathways.
    Igarashi Y; Heureux E; Doctor KS; Talwar P; Gramatikova S; Gramatikoff K; Zhang Y; Blinov M; Ibragimova SS; Boyd S; Ratnikov B; Cieplak P; Godzik A; Smith JW; Osterman AL; Eroshkin AM
    Nucleic Acids Res; 2009 Jan; 37(Database issue):D611-8. PubMed ID: 18842634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The APP Proteolytic System and Its Interactions with Dynamic Networks in Alzheimer's Disease.
    Hunter S; Martin S; Brayne C
    Methods Mol Biol; 2016; 1303():71-99. PubMed ID: 26235060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Immunometabolism Choreography.
    Emambokus N; Granger A; Mott R; Helenius T
    Cell Metab; 2017 Jul; 26(1):1. PubMed ID: 28683277
    [No Abstract]   [Full Text] [Related]  

  • 15. The ubiquitin proteolytic system: from a vague idea, through basic mechanisms, and onto human diseases and drug targeting.
    Ciechanover A
    Neurology; 2006 Jan; 66(2 Suppl 1):S7-19. PubMed ID: 16432150
    [No Abstract]   [Full Text] [Related]  

  • 16. Inflammation and DNA damage: Probing pathways to cancer and neurodegeneration.
    Makvandi M; Sellmyer MA; Mach RH
    Drug Discov Today Technol; 2017 Nov; 25():37-43. PubMed ID: 29233266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular protein degradation: From a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting.
    Ciechanover A
    Best Pract Res Clin Haematol; 2017 Dec; 30(4):341-355. PubMed ID: 29156207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteolytic Cleavage of Polyglutamine Disease-Causing Proteins: Revisiting the Toxic Fragment Hypothesis.
    Matos CA; Almeida LP; Nobrega C
    Curr Pharm Des; 2017; 23(5):753-775. PubMed ID: 28025946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biology of proteostasis in aging and disease.
    Labbadia J; Morimoto RI
    Annu Rev Biochem; 2015; 84():435-64. PubMed ID: 25784053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt/Ca2+ signaling pathway: a brief overview.
    De A
    Acta Biochim Biophys Sin (Shanghai); 2011 Oct; 43(10):745-56. PubMed ID: 21903638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.